HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Calif. bill

This article was originally published in The Rose Sheet

Executive Summary

Legislation that would have required manufacturers to notify the California Office of Environmental Health Hazard Assessment of cosmetic or personal care products containing any ingredient known to cause cancer or reproductive toxicity failed to pass the California State Assembly Committee on Health Aug. 26. Bill was pared down from the version introduced by assembly member Judy Chu (D-49th), which also sought to prohibit the manufacture and sale of products containing phthalates. Legislation passed the Senate Aug. 24, but met opposition in the Assembly (1"The Rose Sheet" July 5, 2004, p. 5). Measure is the second introduced this year by Chu seeking to regulate personal care ingredients. AB 2025, which would have banned known carcinogens and reproductive toxins in cosmetics, was shelved by the health committee in April (2"The Rose Sheet" April 26, 2004, p. 5)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS012401

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel